Carbylan Therapeutics' Series B Round

Carbylan Therapeutics raised a round of funding on November 10, 2007.

Carbylan Therapeutics is a clinical-stage, specialty, pharmaceutical company focused on the development and commercialization of proprietary combination therapies that address significant unmet medica…

Articles about Carbylan Therapeutics' Series B Round: